<p>PBMC were stimulated with either UL138 or gB peptides for 48(control). PBMC were then stimulated or remained unstimulated (Negative) with anti-CD3/CD28 beads for 5 days and where then stained with anti-CD3 and anti-CD4 antibodies, dead cells excluded by the use of 7-amino-actinomycin D. Cells were gated according to (A) and the proliferation of CD4<sup>+</sup> T cells was analysed by flow cytometry (B). The same analysis was performed on three individual donors (C). Error bars are standard error of the mean (n = 3). Statistical analysis was performed using the students t test (p<0.01). The same analysis was performed on PBMC from four separate donors and prior to the addition of PBMC supernatants were treated with neutralising anti-IL-10...
<p>PBMC were primed overnight with LPS concentrations ranging from 0.01 ng/mL to 100 ng/mL (in case ...
<p>(a) Flow cytometry results. The control was normal spleen lymphocytes. The N<sub>71–78</sub> grou...
<p>PBMC from a panel of healthy virus carriers (referred to as D1–D17) were co-cultured with autolog...
B cells were isolated and stimulated with CD40L/LPS/CpG for 2 days. Unstimulated (US) and stimulated...
<p>PBMCs were labelled with CFSE and were analysed by flow cytometry after 5 days of culture. γδ-T c...
<p>The figure shows a schematic representation of the T cell:PBMC assay format: PBMCs were obtained ...
A, B. PBMCs (5 × 105) were stimulated with anti-CD3/CD28/CD2-coated beads with or without preculture...
<p>(a–d) The amount of IFNγ, IL-4, IL-10, and IL-17 secreted into the supernatant was measured by EL...
<p>(A) T cell enriched PBMCs were pretreated with LA prior to stimulation with anti-CD3/CD28 for 72 ...
<p><b>A</b>) Proliferation of PBMCs treated with αCD3/αCD28 in the presence of control mIgG1, αOrai1...
<p>(A,B) OX40/CD25 expression of PBMCs cultured in the presence of increasing amounts of LPS (25–250...
<p>PBMC were first treated with medium (white points) or primed with 10 ng/mL LPS (black points), th...
<p>E14 thymic lobes were cultured in the presence of anti-TβRIII antibody or in the presence of pre-...
For an allogeneic MLR, responder cells from 6 healthy donors were stained with CFSE and mixed with γ...
<p>(<b>A-B</b>) Results of PBMC suppression assay. PBMCs from HIV-1-positive HLA-B*27<sup>+</sup> su...
<p>PBMC were primed overnight with LPS concentrations ranging from 0.01 ng/mL to 100 ng/mL (in case ...
<p>(a) Flow cytometry results. The control was normal spleen lymphocytes. The N<sub>71–78</sub> grou...
<p>PBMC from a panel of healthy virus carriers (referred to as D1–D17) were co-cultured with autolog...
B cells were isolated and stimulated with CD40L/LPS/CpG for 2 days. Unstimulated (US) and stimulated...
<p>PBMCs were labelled with CFSE and were analysed by flow cytometry after 5 days of culture. γδ-T c...
<p>The figure shows a schematic representation of the T cell:PBMC assay format: PBMCs were obtained ...
A, B. PBMCs (5 × 105) were stimulated with anti-CD3/CD28/CD2-coated beads with or without preculture...
<p>(a–d) The amount of IFNγ, IL-4, IL-10, and IL-17 secreted into the supernatant was measured by EL...
<p>(A) T cell enriched PBMCs were pretreated with LA prior to stimulation with anti-CD3/CD28 for 72 ...
<p><b>A</b>) Proliferation of PBMCs treated with αCD3/αCD28 in the presence of control mIgG1, αOrai1...
<p>(A,B) OX40/CD25 expression of PBMCs cultured in the presence of increasing amounts of LPS (25–250...
<p>PBMC were first treated with medium (white points) or primed with 10 ng/mL LPS (black points), th...
<p>E14 thymic lobes were cultured in the presence of anti-TβRIII antibody or in the presence of pre-...
For an allogeneic MLR, responder cells from 6 healthy donors were stained with CFSE and mixed with γ...
<p>(<b>A-B</b>) Results of PBMC suppression assay. PBMCs from HIV-1-positive HLA-B*27<sup>+</sup> su...
<p>PBMC were primed overnight with LPS concentrations ranging from 0.01 ng/mL to 100 ng/mL (in case ...
<p>(a) Flow cytometry results. The control was normal spleen lymphocytes. The N<sub>71–78</sub> grou...
<p>PBMC from a panel of healthy virus carriers (referred to as D1–D17) were co-cultured with autolog...